Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts

Experimental Eye Research

Volumn 93, Issue 5, 2011, Pages 618-627

  Warejcka, Debra J ^a   Narayan, Malathi ^a   Twining, Sally S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cornea; Fibroblast; Maspin; Myofibroblast; Plasminogen activator inhibitor 1; Tissue type plasminogen activator; Turnover; Urinary type plasminogen activator

Indexed keywords

ANGIOSTATIN; MASPIN; MESSENGER RNA; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CELL LYSATE; CELL TYPE; CLEARANCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORNEA CELL; CORNEA INJURY; CORNEA STROMA; EXTRACELLULAR SPACE; FIBROBLAST; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MYOFIBROBLAST; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANGIOSTATINS; BLOTTING, WESTERN; CELLS, CULTURED; CORNEAL STROMA; CYCLOHEXIMIDE; FIBROBLASTS; HUMANS; MYOFIBROBLASTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SERINE PROTEINASE INHIBITORS; SERPINS; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; WOUND HEALING;

EID: 81355161428     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.07.008     Document Type: Article

References (51)

1. Al-Ayyoubi M., Schwartz B.S., Gettins P.G. Maspin binds to urokinase-type and tissue-type plasminogen activator through exosite-exosite interactions. J. Biol. Chem. 2007, 282:19502-19509.
2. Amir S., Margaryan N.V., Odero-Marah V., Khalkhali-Ellis Z., Hendrix M.J. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells. Cancer Biol. Ther. 2005, 4:400-406.
3. Ayala A., Warejcka D.J., Olague-Marchan M., Twining S.S. Corneal activation of prothrombin to form thrombin, independent of vascular injury. Invest. Ophthalmol. Vis. Sci. 2007, 48:134-143.
4. Ayala A., Warejecka D.J., Vaughan K.A., Twining S.S., Yue B.Y. The fibrinolysis inhibitor alpha2-antiplasmin in the human cornea. Curr. Eye Res. 2005, 30:1097-1103.
5. Bailey C.M., Margaryan N.V., Abbott D.E., Schutte B.C., Yang B., Khalkhali-Ellis Z., Hendrix M.J. Temporal and spatial expression patterns for the tumor suppressor Maspin and its binding partner interferon regulatory factor 6 during breast development. Dev. Growth Differ. 2009, 51:473-481.
6. Bass R., Fernandez A.M., Ellis V. Maspin inhibits cell migration in the absence of protease inhibitory activity. J. Biol. Chem. 2002, 277:46845-46848.
7. Berk R.S., Katar M., Dong Z., Day D.E. Plasminogen activators and inhibitors in the corneas of mice infected with Pseudomonas aeruginosa. Invest. Ophthalmol. Vis. Sci. 2001, 42:1561-1567.
8. Bernstein A.M., Greenberg R.S., Taliana L., Masur S.K. Urokinase anchors uPAR to the actin cytoskeleton. Invest. Ophthalmol. Vis. Sci. 2004, 45:2967-2977.
9. Bernstein A.M., Twining S.S., Warejcka D.J., Tall E., Masur S.K. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation. Mol. Biol. Cell 2007, 18:2716-2727.
10. Biliran H., Sheng S. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res. 2001, 61:8676-8682.
11. Binder B.R., Christ G., Gruber F., Grubic N., Hufnagl P., Krebs M., Mihaly J., Prager G.W. Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol. Sci. 2002, 17:56-61.
12. Binder B.R., Mihaly J., Prager G.W. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb. Haemost 2007, 97:336-342.
13. Carmeliet P., Moons L., Lijnen R., Baes M., Lemaitre V., Tipping P., Drew A., Eeckhout Y., Shapiro S., Lupu F., Collen D. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 1997, 17:439-444.
14. Conese M., Nykjaer A., Petersen C.M., Cremona O., Pardi R., Andreasen P.A., Gliemann J., Christensen E.I., Blasi F. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor. J. Cell Biol. 1995, 131:1609-1622.
15. Corti A., Nolli M.L., Soffientini A., Cassani G. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells. Thromb. Haemost 1986, 56:219-224.
16. de Souza G.A., Godoy L.M., Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol. 2006, 7:R72.
17. Drew A.F., Schiman H.L., Kombrinck K.W., Bugge T.H., Degen J.L., Kaufman A.H. Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. Invest. Ophthalmol. Vis. Sci. 2000, 41:67-72.
18. Fini M.E. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog. Retin. Eye Res. 1999, 18:529-551.
19. Gabison E., Chang J.H., Hernandez-Quintela E., Javier J., Lu P.C., Ye H., Kure T., Kato T., Azar D.T. Anti-angiogenic role of angiostatin during corneal wound healing. Exp. Eye Res. 2004, 78:579-589.
20. Grau E., Moroz L.A. Fibrinolytic activity of normal human blood monocytes. Thromb. Res. 1989, 53:145-162.
21. Horswill M.A., Narayan M., Warejcka D.J., Cirillo L.A., Twining S.S. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts. Exp. Eye Res. 2008, 86:586-600.
22. Ishizaki M., Wakamatsu K., Matsunami T., Yamanaka N., Saiga T., Shimizu Y., Zhu G., Kao W.W. Dynamics of the expression of cytoskeleton components and adherens molecules by fibroblastic cells in alkali-burned and lacerated corneas. Exp. Eye Res. 1994, 59:537-549.
23. Ismail B., Choi L.H., Were L.M., Nielsen S.S. Activity and nature of plasminogen activators associated with the casein micelle. J. Dairy Sci. 2006, 89:3285-3295.
24. Jester J.V., Petroll W.M., Barry P.A., Cavanagh H.D. Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest. Ophthalmol.Vis. Sci. 1995, 36:809-819.
25. Kao W.W., Kao C.W., Kaufman A.H., Kombrinck K.W., Converse R.L., Good W.V., Bugge T.H., Degen J.L. Healing of corneal epithelial defects in plasminogen- and fibrinogen-deficient mice. Invest. Ophthalmol. Vis. Sci. 1998, 39:502-508.
26. Matrisian L.M. The matrix-degrading metalloproteinases. Bioessays 1992, 14:455-463.
27. McGowen R., Biliran H., Sager R., Sheng S. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. Cancer Res. 2000, 60:4771-4778.
28. Mohan R.R., Hutcheon A.E., Choi R., Hong J., Lee J., Mohan R.R., Ambrosio R., Zieske J.D., Wilson S.E. Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Exp. Eye Res. 2003, 76:71-87.
29. Narayan M., Twining S. Focus on molecules: maspin. Exp. Eye Res. 2010, 90:2-3.
30. Ngamkitidechakul C., Burke J.M., O'Brien W.J., Twining S.S. Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix. Invest. Ophthalmol. Vis. Sci. 2001, 42:3135-3141.
31. Ngamkitidechakul C., Twining S.S. Buffered non-fermenter system for lab-scale production of secreted recombinant His-tagged proteins in Saccharomyces cerevisiae. Biotechniques 2002, 33:1296-1300.
32. Ngamkitidechakul C., Warejcka D.J., Burke J.M., O'Brien W.J., Twining S.S. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. J. Biol. Chem. 2003, 278:31796-31806.
33. Nykjaer A., Christensen E.I., Vorum H., Hager H., Petersen C.M., Roigaard H., Min H.Y., Vilhardt F., Moller L.B., Kornfeld S., Gliemann J. Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction. J. Cell Biol. 1998, 141:815-828.
34. Ottino P., Taheri F., Bazan H.E. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2. Exp. Eye Res. 2002, 74:393-402.
35. Petroll W.M., Jester J.V., Barry-Lane P.A., Cavanagh H.D. Effects of basic FGF and TGF beta 1 on F-actin and ZO-1 organization during cat endothelial wound healing. Cornea 1996, 15:525-532.
36. Ritchie H., Booth N.A. Secretion of plasminogen activator inhibitor 2 by human peripheral blood monocytes occurs via an endoplasmic reticulum-golgi-independent pathway. Exp. Cell Res. 1998, 242:439-450.
37. Seftor R.E., Seftor E.A., Sheng S., Pemberton P.A., Sager R., Hendrix M.J. maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res. 1998, 58:5681-5685.
38. Stramer B.M., Zieske J.D., Jung J.C., Austin J.S., Fini M.E. Molecular mechanisms controlling the fibrotic repair phenotype in cornea: implications for surgical outcomes. Invest. Ophthalmol. Vis. Sci. 2003, 44:4237-4246.
39. Taylor J.L., Casey M.S., O'Brien W.J. Synergistic antiherpes virus activity of acyclovir and interferon in human corneal stromal cells. Invest. Ophthalmol. Vis. Sci. 1989, 30:365-370.
40. Teoh S.S., Whisstock J.C., Bird P.I. Maspin (SERPINB5) is an obligate intracellular serpin. J. Biol. Chem. 2010, 285:10862-10869.
41. Twining S.S. Fluorescein isothiocyanate-labeled casein assay for proteolytic enzymes. Anal. Biochem. 1984, 143:30-34.
42. Twining S.S., Fukuchi T., Yue B.Y., Wilson P.M., Zhou X., Loushin G. Alpha 2-macroglobulin is present in and synthesized by the cornea. Invest. Ophthalmol. Vis. Sci. 1994, 35:3226-3233.
43. Twining S.S., Wilson P.M., Ngamkitidechakul C. Extrahepatic synthesis of plasminogen in the human cornea is up-regulated by interleukins-1alpha and -1beta. Biochem. J. 1999, 339(Pt 3):705-712.
44. Warejcka D.J., Vaughan K.A., Bernstein A.M., Twining S.S. Differential conversion of plasminogen to angiostatin by human corneal cell populations. Mol. Vis. 2005, 11:859-868.
45. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997, 91:439-442.
46. West-Mays J.A., Sadow P.M., Tobin T.W., Strissel K.J., Cintron C., Fini M.E. Repair phenotype in corneal fibroblasts is controlled by an interleukin-1 alpha autocrine feedback loop. Invest. Ophthalmol. Vis. Sci. 1997, 38:1367-1379.
47. Woessner J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991, 5:2145-2154.
48. Zhang G., Cai X., Lopez-Guisa J.M., Collins S.J., Eddy A.A. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein. J. Am. Soc. Nephrol. 2004, 15:2090-2102.
49. Zhang G., Kernan K.A., Thomas A., Collins S., Song Y., Li L., Zhu W., Leboeuf R.C., Eddy A.A. A novel signaling pathway: fibroblast nicotinic receptor alpha1 binds urokinase and promotes renal fibrosis. J. Biol. Chem. 2009, 284:29050-29064.
50. Zhang M., Volpert O., Shi Y.H., Bouck N. Maspin is an angiogenesis inhibitor. Nat. Med. 2000, 6:196-199.
51. Zou Z., Anisowicz A., Hendrix M.J., Thor A., Neveu M., Sheng S., Rafidi K., Seftor E., Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994, 263:526-529.